Explore our high-precision equipment portfolio engineered for clinical labs, research institutes, and industrial quality control ecosystems.
Shenzhen BioX Medical Co., Ltd. — Driving global excellence in clinical diagnostics and molecular pathology.
Shenzhen BioX Medical Co., Ltd. is a premier high-tech enterprise specializing in the design, engineering, and large-scale manufacturing of modern molecular diagnostic analysis systems, genetic testing solutions, and comprehensive clinical laboratory equipment. Established in 2017, the company operates from its state-of-the-art headquarters in Shenzhen, China — the global epicenter for biotechnology innovation, advanced medical device R&D, and high-precision electronics manufacturing.
Spanning an ultra-modern manufacturing footprint of over 9,000 square meters and powered by a dedicated multidisciplinary workforce of over 200 skilled engineers, scientists, and technicians, BioX Medical is committed to delivering end-to-end diagnostic instruments. Our operational matrix bridges the gap between complex academic innovation and practical clinical application, enabling hospital systems, public health institutions, reference laboratories, and biotech companies worldwide to achieve unprecedented diagnostic accuracy.
The company's broad portfolio encompasses real-time quantitative PCR platforms, nucleic acid extraction automatons, genetic sequence analyzers, pathogen screening solutions, biomarker detection devices, and fully automated diagnostic workstations. By combining microfluidic engineering, optical sensor systems, dynamic temperature control, and AI-driven data management, BioX Medical equips modern healthcare providers with scalable, robust, and cost-efficient disease management tools.
Bridging diagnostic precision, real-time analytics, and automated workflows across diverse clinical domains.
High-sensitivity fluorescence-based PCR and nucleic acid workstations designed for early pathogen detection, viral load monitoring, and mutation surveillance. Engineered for absolute specificity and zero cross-contamination.
Integration of 3D motion-capture arrays, gait analysis platforms, and pressure distribution sensors to deliver full-body mechanical diagnostics for podiatry, orthopedics, and rehabilitation tracking.
CE-certified rapid diagnostic platforms specifically built for agricultural and domestic veterinary applications, protecting biosafety via rapid viral, bacterial, and antigenic testing kits.
Our solutions feature open-protocol architecture compatible with global LIMS (Laboratory Information Management Systems), facilitating standardized data pipelines, real-time epidemiological monitoring, and seamless clinical decision support.
| Diagnostic Application | Core Analytical Technology | Detection Limit / Resolution | Target Clinical Domain |
|---|---|---|---|
| Real-Time Quant Quantitative PCR | Multi-channel LED Fluorescence Spectroscopy | < 10 copies/mL (Nucleic Acid) | Oncology, Infectious Disease, Rare Genetic Profiling |
| Automated Microbial Identification | Biochemical Colorimetric & Turbidimetric Arrays | 99.2% Species Accuracy | Hospital Infection Control, Bio-Pharma QC |
| 3D Dynamic Gait & Podiatry Platform | AI Vision Matrix + High-Density Piezo Sensors | 0.5 mm spatial / 200 Hz temporal | Diabetic Foot Management, Orthopedics |
| Clinical Urodynamic Evaluation | Multi-Channel Hydrostatic Pressure Transducers | ±0.5% Full Scale Accuracy | Urology, Neurological Bladder Dysfunction |
Leveraging Shenzhen's biotech ecosystem to guarantee rigorous quality control, rapid OEM scaling, and global supply stability.
Our 9,000 m² cleanroom manufacturing facility utilizes automated Surface Mount Technology (SMT) lines, robotic optical alignment systems, and rigorous temperature-cycling stress testing. Every instrument undergoes automated 100% End-of-Line (EOL) calibration to guarantee ISO 13485 compliance before dispatch.
From custom optical filter blocks and specialized fluidic cartridges to white-labeled software interfaces and localized electrical certifications (CE, FCC, UL), BioX Medical delivers scalable OEM/ODM partnerships tailored to international brand specifications.
Architecting next-generation point-of-care tools through synthetic biology, microfluidics, and edge-AI intelligence.
Transitioning complex lab assays into fully enclosed, disposable microfluidic cartridges. Shrinking diagnostic reaction times from hours to under 15 minutes without sacrificing analytical sensitivity.
Embedding localized neural processing units (NPUs) inside diagnostic hardware for real-time anomaly detection, automated curve analysis, and instant diagnostic reporting connected to global health databases.
Pioneering ultra-sensitive digital PCR (dPCR) platforms aimed at non-invasive circulating tumor DNA (ctDNA) quantification and early-stage chronic metabolic disorder tracking.
Providing seamlessly integrated regulatory, logistical, and technical guarantees for international distributors and hospital networks.
Procuring disease management instruments and molecular laboratory infrastructure requires strict compliance with international medical device directives, environmental standards, and data security frameworks. BioX Medical maintains an international regulatory compliance taskforce dedicated to supporting enterprise buyers through every stage of acquisition.
Full CE-IVD, ISO 13485:2016, and RoHS compliance documentation provided alongside technical construction files for expedited local FDA/MDR registration.
Robust international packaging solutions including shock-monitored ambient transit structures and controlled cold-chain reagent freight coordination.
Comprehensive remote and on-site technical training modules, certifying regional distributor engineers in system maintenance, calibration, and repair.
Software architectures compliant with HIPAA and GDPR data regulations, supporting local database installation and encrypted cloud synchronization.
Expert insights into manufacturing capabilities, regulatory support, OEM/ODM processes, and instrument integration.
BioX Medical combines a modern 9,000+ m² ISO 13485-certified production facility with over 200 specialized staff members in Shenzhen's core biotech corridor. Our focus on integrated R&D—spanning optical engineering, fluidics, thermal control, and software automation—allows us to deliver clinical-grade molecular diagnostic platforms and analysis equipment that meet stringent global quality standards at competitive factory-direct terms.
Yes. BioX Medical offers complete OEM and ODM customization services. We support custom hardware branding, specific optical channel configurations (e.g., tailored LED excitation wavelength ranges), bespoke reagent cartridge engineering, localized power supply designs, and custom LIMS software white-labeling to fit your market needs.
Our core medical diagnostic devices and analytical instruments comply with international frameworks, including ISO 13485:2016 quality management system standards and CE-IVD markings. We supply complete technical dossiers (STED format) to facilitate rapid local registration with health authorities across Europe, APAC, Latin America, the Middle East, and Africa.
We provide a comprehensive warranty package (typically 12 to 24 months, expandable upon contract) backed by remote diagnostic telemetry, spare part modular replacement kits, and dedicated technical support. Distributor service engineers receive full video, documentation, and live video-based factory certification training.
Our real-time quantitative PCR systems (such as the Gentier series) utilize ultra-stable long-life LED excitation sources combined with high-sensitivity photomultiplier tube (PMT) or modern CMOS optical detection arrays. Coupled with precision semiconductor Peltier heating/cooling modules, our systems achieve fast ramp rates and uniform temperature distribution (±0.1°C), ensuring maximum amplification efficiency and accurate Cq value calling.
Explore our full line of clinical analyzers, real-time quantitative PCR systems, dynamic gait scanners, and precision testing platforms.